Brief: Cvrx Announces Initiation Of Benefit-Hf, A Landmark Heart Failure Trial

CVRx

22/01/2026 23:10

Jan 22 (Reuters) - CVRx Inc CVRX.O:

CVRX ANNOUNCES INITIATION OF BENEFIT-HF, A LANDMARK HEART FAILURE TRIAL EVALUATING BAROSTIM IN SIGNIFICANTLY EXPANDED POPULATION

CVRX INC - PRIMARY ENDPOINT: ALL-CAUSE MORTALITY AND HEART FAILURE DECOMPENSATION EVENTS

CVRX INC - ENROLLMENT IS EXPECTED TO BEGIN IN THE FIRST HALF OF 2026

Source text: ID:nGNX8GlVcG

Further company coverage: CVRX.O

 ((Reuters.Briefs@thomsonreuters.com;))